Clinical Trial Update: Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants

View source ↗

Summary

Clinical trial update describing expanded access to T-cell-depleted haplo-identical stem cells for patients undergoing haplo-identical or unrelated cord blood t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Immune Deficiencies
• Inborn Errors of Metabolism

Drugs mentioned

• Haplo-identical stem cell transplantation with T-cell depletion

Snippet

Sponsor: Joanne Kurtzberg, MD | Conditions: Hematologic Malignancies, Inborn Errors of Metabolism Disorders | Status: AVAILABLE